nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—Mitoxantrone—lymphatic system cancer	0.0296	0.261	CbGbCtD
Captopril—SLC22A6—Methotrexate—lymphatic system cancer	0.0276	0.244	CbGbCtD
Captopril—ALB—Methotrexate—lymphatic system cancer	0.0235	0.208	CbGbCtD
Captopril—ABCB1—Vincristine—lymphatic system cancer	0.0203	0.179	CbGbCtD
Captopril—ABCB1—Methotrexate—lymphatic system cancer	0.0123	0.109	CbGbCtD
Captopril—Necrosis—Methotrexate—lymphatic system cancer	0.0027	0.00305	CcSEcCtD
Captopril—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00269	0.00304	CcSEcCtD
Captopril—Neutropenia—Carmustine—lymphatic system cancer	0.00269	0.00303	CcSEcCtD
Captopril—Arthralgia—Fludarabine—lymphatic system cancer	0.00266	0.003	CcSEcCtD
Captopril—Myalgia—Fludarabine—lymphatic system cancer	0.00266	0.003	CcSEcCtD
Captopril—Discomfort—Fludarabine—lymphatic system cancer	0.00263	0.00297	CcSEcCtD
Captopril—Pancytopenia—Vincristine—lymphatic system cancer	0.0026	0.00294	CcSEcCtD
Captopril—Dyspnoea—Teniposide—lymphatic system cancer	0.00259	0.00292	CcSEcCtD
Captopril—Confusional state—Fludarabine—lymphatic system cancer	0.00257	0.0029	CcSEcCtD
Captopril—Neutropenia—Vincristine—lymphatic system cancer	0.00256	0.00289	CcSEcCtD
Captopril—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00255	0.00288	CcSEcCtD
Captopril—Pancytopenia—Mitoxantrone—lymphatic system cancer	0.00254	0.00286	CcSEcCtD
Captopril—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00252	0.00285	CcSEcCtD
Captopril—Decreased appetite—Teniposide—lymphatic system cancer	0.00252	0.00285	CcSEcCtD
Captopril—Renal failure—Carmustine—lymphatic system cancer	0.00252	0.00284	CcSEcCtD
Captopril—Vomiting—Mechlorethamine—lymphatic system cancer	0.0025	0.00282	CcSEcCtD
Captopril—Photosensitivity reaction—Vincristine—lymphatic system cancer	0.0025	0.00282	CcSEcCtD
Captopril—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.0025	0.00282	CcSEcCtD
Captopril—Neutropenia—Mitoxantrone—lymphatic system cancer	0.0025	0.00282	CcSEcCtD
Captopril—Stomatitis—Carmustine—lymphatic system cancer	0.0025	0.00281	CcSEcCtD
Captopril—Rash—Mechlorethamine—lymphatic system cancer	0.00248	0.0028	CcSEcCtD
Captopril—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00248	0.0028	CcSEcCtD
Captopril—Weight decreased—Vincristine—lymphatic system cancer	0.00248	0.0028	CcSEcCtD
Captopril—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00246	0.00277	CcSEcCtD
Captopril—Flushing—Bleomycin—lymphatic system cancer	0.00244	0.00276	CcSEcCtD
Captopril—Anorexia—Fludarabine—lymphatic system cancer	0.00243	0.00274	CcSEcCtD
Captopril—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00242	0.00272	CcSEcCtD
Captopril—Proteinuria—Methotrexate—lymphatic system cancer	0.00241	0.00272	CcSEcCtD
Captopril—Feeling abnormal—Teniposide—lymphatic system cancer	0.00239	0.0027	CcSEcCtD
Captopril—Stomatitis—Vincristine—lymphatic system cancer	0.00238	0.00269	CcSEcCtD
Captopril—Protein urine present—Methotrexate—lymphatic system cancer	0.00238	0.00268	CcSEcCtD
Captopril—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00237	0.00268	CcSEcCtD
Captopril—Renal failure—Mitoxantrone—lymphatic system cancer	0.00234	0.00264	CcSEcCtD
Captopril—Nausea—Mechlorethamine—lymphatic system cancer	0.00234	0.00264	CcSEcCtD
Captopril—Alopecia—Bleomycin—lymphatic system cancer	0.00233	0.00262	CcSEcCtD
Captopril—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00232	0.00262	CcSEcCtD
Captopril—Stomatitis—Mitoxantrone—lymphatic system cancer	0.00232	0.00262	CcSEcCtD
Captopril—Jaundice—Mitoxantrone—lymphatic system cancer	0.00232	0.00262	CcSEcCtD
Captopril—Glossitis—Methotrexate—lymphatic system cancer	0.0023	0.00259	CcSEcCtD
Captopril—Oliguria—Methotrexate—lymphatic system cancer	0.0023	0.00259	CcSEcCtD
Captopril—Body temperature increased—Teniposide—lymphatic system cancer	0.00229	0.00259	CcSEcCtD
Captopril—Abdominal pain—Teniposide—lymphatic system cancer	0.00229	0.00259	CcSEcCtD
Captopril—Paraesthesia—Fludarabine—lymphatic system cancer	0.00229	0.00258	CcSEcCtD
Captopril—Hallucination—Carmustine—lymphatic system cancer	0.00229	0.00258	CcSEcCtD
Captopril—Dyspnoea—Fludarabine—lymphatic system cancer	0.00227	0.00257	CcSEcCtD
Captopril—Dyspepsia—Fludarabine—lymphatic system cancer	0.00225	0.00253	CcSEcCtD
Captopril—Ulcer—Methotrexate—lymphatic system cancer	0.00224	0.00253	CcSEcCtD
Captopril—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00222	0.00251	CcSEcCtD
Captopril—Decreased appetite—Fludarabine—lymphatic system cancer	0.00222	0.0025	CcSEcCtD
Captopril—Fatigue—Fludarabine—lymphatic system cancer	0.0022	0.00248	CcSEcCtD
Captopril—Hallucination—Vincristine—lymphatic system cancer	0.00218	0.00246	CcSEcCtD
Captopril—Constipation—Fludarabine—lymphatic system cancer	0.00218	0.00246	CcSEcCtD
Captopril—Vasculitis—Methotrexate—lymphatic system cancer	0.00217	0.00245	CcSEcCtD
Captopril—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00214	0.00242	CcSEcCtD
Captopril—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00214	0.00241	CcSEcCtD
Captopril—Flushing—Carmustine—lymphatic system cancer	0.00213	0.00241	CcSEcCtD
Captopril—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00213	0.0024	CcSEcCtD
Captopril—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00212	0.00239	CcSEcCtD
Captopril—Anaemia—Bleomycin—lymphatic system cancer	0.00212	0.00239	CcSEcCtD
Captopril—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0021	0.00237	CcSEcCtD
Captopril—Asthenia—Teniposide—lymphatic system cancer	0.00208	0.00235	CcSEcCtD
Captopril—Malaise—Bleomycin—lymphatic system cancer	0.00207	0.00233	CcSEcCtD
Captopril—Pruritus—Teniposide—lymphatic system cancer	0.00205	0.00232	CcSEcCtD
Captopril—Alopecia—Carmustine—lymphatic system cancer	0.00203	0.00229	CcSEcCtD
Captopril—Body temperature increased—Fludarabine—lymphatic system cancer	0.00202	0.00228	CcSEcCtD
Captopril—Cough—Bleomycin—lymphatic system cancer	0.002	0.00226	CcSEcCtD
Captopril—Diarrhoea—Teniposide—lymphatic system cancer	0.00199	0.00224	CcSEcCtD
Captopril—Chest pain—Bleomycin—lymphatic system cancer	0.00195	0.0022	CcSEcCtD
Captopril—Myalgia—Bleomycin—lymphatic system cancer	0.00195	0.0022	CcSEcCtD
Captopril—Alopecia—Vincristine—lymphatic system cancer	0.00194	0.00219	CcSEcCtD
Captopril—Discomfort—Bleomycin—lymphatic system cancer	0.00193	0.00217	CcSEcCtD
Captopril—Urine output increased—Methotrexate—lymphatic system cancer	0.00192	0.00216	CcSEcCtD
Captopril—Gynaecomastia—Methotrexate—lymphatic system cancer	0.0019	0.00214	CcSEcCtD
Captopril—Alopecia—Mitoxantrone—lymphatic system cancer	0.00189	0.00213	CcSEcCtD
Captopril—Confusional state—Bleomycin—lymphatic system cancer	0.00189	0.00213	CcSEcCtD
Captopril—Vision blurred—Carmustine—lymphatic system cancer	0.00189	0.00213	CcSEcCtD
Captopril—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00187	0.00211	CcSEcCtD
Captopril—Anaemia—Carmustine—lymphatic system cancer	0.00185	0.00209	CcSEcCtD
Captopril—Vomiting—Teniposide—lymphatic system cancer	0.00185	0.00208	CcSEcCtD
Captopril—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00183	0.00207	CcSEcCtD
Captopril—Asthenia—Fludarabine—lymphatic system cancer	0.00183	0.00206	CcSEcCtD
Captopril—Rash—Teniposide—lymphatic system cancer	0.00183	0.00206	CcSEcCtD
Captopril—Dermatitis—Teniposide—lymphatic system cancer	0.00183	0.00206	CcSEcCtD
Captopril—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00182	0.00205	CcSEcCtD
Captopril—Headache—Teniposide—lymphatic system cancer	0.00182	0.00205	CcSEcCtD
Captopril—Pruritus—Fludarabine—lymphatic system cancer	0.00181	0.00204	CcSEcCtD
Captopril—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.0018	0.00203	CcSEcCtD
Captopril—Anorexia—Bleomycin—lymphatic system cancer	0.00178	0.00201	CcSEcCtD
Captopril—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.00177	0.002	CcSEcCtD
Captopril—Anaemia—Vincristine—lymphatic system cancer	0.00177	0.00199	CcSEcCtD
Captopril—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00175	0.00198	CcSEcCtD
Captopril—Photosensitivity—Methotrexate—lymphatic system cancer	0.00175	0.00198	CcSEcCtD
Captopril—Polyuria—Methotrexate—lymphatic system cancer	0.00175	0.00198	CcSEcCtD
Captopril—Hypotension—Bleomycin—lymphatic system cancer	0.00175	0.00197	CcSEcCtD
Captopril—Diarrhoea—Fludarabine—lymphatic system cancer	0.00175	0.00197	CcSEcCtD
Captopril—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00173	0.00195	CcSEcCtD
Captopril—Nausea—Teniposide—lymphatic system cancer	0.00172	0.00195	CcSEcCtD
Captopril—Anaemia—Mitoxantrone—lymphatic system cancer	0.00172	0.00194	CcSEcCtD
Captopril—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.0017	0.00192	CcSEcCtD
Captopril—Chest pain—Carmustine—lymphatic system cancer	0.0017	0.00192	CcSEcCtD
Captopril—Myalgia—Carmustine—lymphatic system cancer	0.0017	0.00192	CcSEcCtD
Captopril—Paraesthesia—Bleomycin—lymphatic system cancer	0.00168	0.00189	CcSEcCtD
Captopril—Malaise—Mitoxantrone—lymphatic system cancer	0.00168	0.00189	CcSEcCtD
Captopril—Dyspnoea—Bleomycin—lymphatic system cancer	0.00167	0.00188	CcSEcCtD
Captopril—Renal failure acute—Methotrexate—lymphatic system cancer	0.00167	0.00188	CcSEcCtD
Captopril—Confusional state—Carmustine—lymphatic system cancer	0.00165	0.00186	CcSEcCtD
Captopril—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00163	0.00184	CcSEcCtD
Captopril—Decreased appetite—Bleomycin—lymphatic system cancer	0.00163	0.00183	CcSEcCtD
Captopril—Myalgia—Vincristine—lymphatic system cancer	0.00163	0.00183	CcSEcCtD
Captopril—Cough—Mitoxantrone—lymphatic system cancer	0.00162	0.00183	CcSEcCtD
Captopril—Vomiting—Fludarabine—lymphatic system cancer	0.00162	0.00183	CcSEcCtD
Captopril—Rash—Fludarabine—lymphatic system cancer	0.00161	0.00181	CcSEcCtD
Captopril—Dermatitis—Fludarabine—lymphatic system cancer	0.00161	0.00181	CcSEcCtD
Captopril—Thrombocytopenia—Carmustine—lymphatic system cancer	0.0016	0.0018	CcSEcCtD
Captopril—Headache—Fludarabine—lymphatic system cancer	0.0016	0.0018	CcSEcCtD
Captopril—Tachycardia—Carmustine—lymphatic system cancer	0.00159	0.0018	CcSEcCtD
Captopril—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00159	0.00179	CcSEcCtD
Captopril—Myalgia—Mitoxantrone—lymphatic system cancer	0.00158	0.00179	CcSEcCtD
Captopril—Chest pain—Mitoxantrone—lymphatic system cancer	0.00158	0.00179	CcSEcCtD
Captopril—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00158	0.00179	CcSEcCtD
Captopril—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00157	0.00177	CcSEcCtD
Captopril—Discomfort—Mitoxantrone—lymphatic system cancer	0.00156	0.00176	CcSEcCtD
Captopril—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00156	0.00176	CcSEcCtD
Captopril—Anorexia—Carmustine—lymphatic system cancer	0.00156	0.00176	CcSEcCtD
Captopril—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00154	0.00174	CcSEcCtD
Captopril—Confusional state—Mitoxantrone—lymphatic system cancer	0.00153	0.00173	CcSEcCtD
Captopril—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00153	0.00172	CcSEcCtD
Captopril—Hypotension—Carmustine—lymphatic system cancer	0.00153	0.00172	CcSEcCtD
Captopril—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00152	0.00171	CcSEcCtD
Captopril—Nausea—Fludarabine—lymphatic system cancer	0.00152	0.00171	CcSEcCtD
Captopril—Shock—Mitoxantrone—lymphatic system cancer	0.00149	0.00168	CcSEcCtD
Captopril—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00149	0.00168	CcSEcCtD
Captopril—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00149	0.00168	CcSEcCtD
Captopril—Anorexia—Vincristine—lymphatic system cancer	0.00149	0.00168	CcSEcCtD
Captopril—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00148	0.00167	CcSEcCtD
Captopril—Body temperature increased—Bleomycin—lymphatic system cancer	0.00148	0.00167	CcSEcCtD
Captopril—Insomnia—Carmustine—lymphatic system cancer	0.00148	0.00167	CcSEcCtD
Captopril—Paraesthesia—Carmustine—lymphatic system cancer	0.00147	0.00165	CcSEcCtD
Captopril—Hypotension—Vincristine—lymphatic system cancer	0.00146	0.00164	CcSEcCtD
Captopril—Dyspnoea—Carmustine—lymphatic system cancer	0.00146	0.00164	CcSEcCtD
Captopril—Somnolence—Carmustine—lymphatic system cancer	0.00145	0.00164	CcSEcCtD
Captopril—Anorexia—Mitoxantrone—lymphatic system cancer	0.00145	0.00163	CcSEcCtD
Captopril—Ataxia—Methotrexate—lymphatic system cancer	0.00145	0.00163	CcSEcCtD
Captopril—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00142	0.0016	CcSEcCtD
Captopril—Decreased appetite—Carmustine—lymphatic system cancer	0.00142	0.0016	CcSEcCtD
Captopril—Hypotension—Mitoxantrone—lymphatic system cancer	0.00142	0.0016	CcSEcCtD
Captopril—Insomnia—Vincristine—lymphatic system cancer	0.00141	0.00159	CcSEcCtD
Captopril—Paraesthesia—Vincristine—lymphatic system cancer	0.0014	0.00158	CcSEcCtD
Captopril—Constipation—Carmustine—lymphatic system cancer	0.0014	0.00158	CcSEcCtD
Captopril—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00138	0.00156	CcSEcCtD
Captopril—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00136	0.00154	CcSEcCtD
Captopril—Decreased appetite—Vincristine—lymphatic system cancer	0.00136	0.00153	CcSEcCtD
Captopril—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00135	0.00153	CcSEcCtD
Captopril—Somnolence—Mitoxantrone—lymphatic system cancer	0.00135	0.00152	CcSEcCtD
Captopril—Feeling abnormal—Carmustine—lymphatic system cancer	0.00135	0.00152	CcSEcCtD
Captopril—Fatigue—Vincristine—lymphatic system cancer	0.00134	0.00152	CcSEcCtD
Captopril—Asthenia—Bleomycin—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Captopril—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Captopril—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00134	0.00151	CcSEcCtD
Captopril—Constipation—Vincristine—lymphatic system cancer	0.00133	0.0015	CcSEcCtD
Captopril—Pruritus—Bleomycin—lymphatic system cancer	0.00132	0.00149	CcSEcCtD
Captopril—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00132	0.00149	CcSEcCtD
Captopril—Eosinophilia—Methotrexate—lymphatic system cancer	0.00132	0.00149	CcSEcCtD
Captopril—Fatigue—Mitoxantrone—lymphatic system cancer	0.00131	0.00148	CcSEcCtD
Captopril—Pancreatitis—Methotrexate—lymphatic system cancer	0.0013	0.00147	CcSEcCtD
Captopril—Constipation—Mitoxantrone—lymphatic system cancer	0.0013	0.00146	CcSEcCtD
Captopril—Body temperature increased—Carmustine—lymphatic system cancer	0.00129	0.00146	CcSEcCtD
Captopril—Abdominal pain—Carmustine—lymphatic system cancer	0.00129	0.00146	CcSEcCtD
Captopril—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00127	0.00144	CcSEcCtD
Captopril—Pancytopenia—Methotrexate—lymphatic system cancer	0.00126	0.00142	CcSEcCtD
Captopril—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00125	0.00141	CcSEcCtD
Captopril—Neutropenia—Methotrexate—lymphatic system cancer	0.00124	0.0014	CcSEcCtD
Captopril—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00124	0.0014	CcSEcCtD
Captopril—Body temperature increased—Vincristine—lymphatic system cancer	0.00123	0.00139	CcSEcCtD
Captopril—Abdominal pain—Vincristine—lymphatic system cancer	0.00123	0.00139	CcSEcCtD
Captopril—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00123	0.00138	CcSEcCtD
Captopril—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.00121	0.00137	CcSEcCtD
Captopril—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0012	0.00135	CcSEcCtD
Captopril—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0012	0.00135	CcSEcCtD
Captopril—Vomiting—Bleomycin—lymphatic system cancer	0.00119	0.00134	CcSEcCtD
Captopril—Rash—Bleomycin—lymphatic system cancer	0.00118	0.00133	CcSEcCtD
Captopril—Dermatitis—Bleomycin—lymphatic system cancer	0.00118	0.00133	CcSEcCtD
Captopril—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00118	0.00133	CcSEcCtD
Captopril—Asthenia—Carmustine—lymphatic system cancer	0.00117	0.00132	CcSEcCtD
Captopril—Renal failure—Methotrexate—lymphatic system cancer	0.00117	0.00131	CcSEcCtD
Captopril—Stomatitis—Methotrexate—lymphatic system cancer	0.00116	0.0013	CcSEcCtD
Captopril—Asthenia—Vincristine—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Captopril—Diarrhoea—Carmustine—lymphatic system cancer	0.00112	0.00126	CcSEcCtD
Captopril—Nausea—Bleomycin—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Captopril—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00111	0.00125	CcSEcCtD
Captopril—Asthenia—Mitoxantrone—lymphatic system cancer	0.00109	0.00123	CcSEcCtD
Captopril—Dizziness—Carmustine—lymphatic system cancer	0.00108	0.00122	CcSEcCtD
Captopril—Diarrhoea—Vincristine—lymphatic system cancer	0.00107	0.0012	CcSEcCtD
Captopril—Hepatitis—Methotrexate—lymphatic system cancer	0.00106	0.0012	CcSEcCtD
Captopril—Pharyngitis—Methotrexate—lymphatic system cancer	0.00106	0.00119	CcSEcCtD
Captopril—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Captopril—Vomiting—Carmustine—lymphatic system cancer	0.00104	0.00117	CcSEcCtD
Captopril—Dizziness—Vincristine—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Captopril—Rash—Carmustine—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Captopril—Dermatitis—Carmustine—lymphatic system cancer	0.00103	0.00116	CcSEcCtD
Captopril—Headache—Carmustine—lymphatic system cancer	0.00102	0.00115	CcSEcCtD
Captopril—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00101	0.00114	CcSEcCtD
Captopril—Vomiting—Vincristine—lymphatic system cancer	0.000991	0.00112	CcSEcCtD
Captopril—Rash—Vincristine—lymphatic system cancer	0.000983	0.00111	CcSEcCtD
Captopril—Dermatitis—Vincristine—lymphatic system cancer	0.000982	0.00111	CcSEcCtD
Captopril—Headache—Vincristine—lymphatic system cancer	0.000977	0.0011	CcSEcCtD
Captopril—Nausea—Carmustine—lymphatic system cancer	0.00097	0.00109	CcSEcCtD
Captopril—Vomiting—Mitoxantrone—lymphatic system cancer	0.000965	0.00109	CcSEcCtD
Captopril—Rash—Mitoxantrone—lymphatic system cancer	0.000957	0.00108	CcSEcCtD
Captopril—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000956	0.00108	CcSEcCtD
Captopril—Headache—Mitoxantrone—lymphatic system cancer	0.000951	0.00107	CcSEcCtD
Captopril—Alopecia—Methotrexate—lymphatic system cancer	0.000941	0.00106	CcSEcCtD
Captopril—Nausea—Vincristine—lymphatic system cancer	0.000926	0.00104	CcSEcCtD
Captopril—Dysgeusia—Methotrexate—lymphatic system cancer	0.000908	0.00102	CcSEcCtD
Captopril—Nausea—Mitoxantrone—lymphatic system cancer	0.000902	0.00102	CcSEcCtD
Captopril—Vision blurred—Methotrexate—lymphatic system cancer	0.000873	0.000985	CcSEcCtD
Captopril—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00086	0.00097	CcSEcCtD
Captopril—Anaemia—Methotrexate—lymphatic system cancer	0.000857	0.000966	CcSEcCtD
Captopril—Malaise—Methotrexate—lymphatic system cancer	0.000836	0.000943	CcSEcCtD
Captopril—Cough—Methotrexate—lymphatic system cancer	0.000809	0.000912	CcSEcCtD
Captopril—Chest pain—Methotrexate—lymphatic system cancer	0.000789	0.00089	CcSEcCtD
Captopril—Myalgia—Methotrexate—lymphatic system cancer	0.000789	0.00089	CcSEcCtD
Captopril—Arthralgia—Methotrexate—lymphatic system cancer	0.000789	0.00089	CcSEcCtD
Captopril—Discomfort—Methotrexate—lymphatic system cancer	0.00078	0.000879	CcSEcCtD
Captopril—Confusional state—Methotrexate—lymphatic system cancer	0.000763	0.00086	CcSEcCtD
Captopril—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000756	0.000853	CcSEcCtD
Captopril—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000741	0.000835	CcSEcCtD
Captopril—Anorexia—Methotrexate—lymphatic system cancer	0.000721	0.000813	CcSEcCtD
Captopril—Hypotension—Methotrexate—lymphatic system cancer	0.000707	0.000797	CcSEcCtD
Captopril—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000689	0.000777	CcSEcCtD
Captopril—Insomnia—Methotrexate—lymphatic system cancer	0.000684	0.000772	CcSEcCtD
Captopril—Paraesthesia—Methotrexate—lymphatic system cancer	0.000679	0.000766	CcSEcCtD
Captopril—Dyspnoea—Methotrexate—lymphatic system cancer	0.000674	0.000761	CcSEcCtD
Captopril—Somnolence—Methotrexate—lymphatic system cancer	0.000672	0.000758	CcSEcCtD
Captopril—Dyspepsia—Methotrexate—lymphatic system cancer	0.000666	0.000751	CcSEcCtD
Captopril—Decreased appetite—Methotrexate—lymphatic system cancer	0.000658	0.000742	CcSEcCtD
Captopril—Fatigue—Methotrexate—lymphatic system cancer	0.000652	0.000736	CcSEcCtD
Captopril—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000623	0.000703	CcSEcCtD
Captopril—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000619	0.000698	CcSEcCtD
Captopril—Abdominal pain—Methotrexate—lymphatic system cancer	0.000598	0.000674	CcSEcCtD
Captopril—Body temperature increased—Methotrexate—lymphatic system cancer	0.000598	0.000674	CcSEcCtD
Captopril—Asthenia—Methotrexate—lymphatic system cancer	0.000543	0.000612	CcSEcCtD
Captopril—Pruritus—Methotrexate—lymphatic system cancer	0.000535	0.000604	CcSEcCtD
Captopril—Diarrhoea—Methotrexate—lymphatic system cancer	0.000518	0.000584	CcSEcCtD
Captopril—Dizziness—Methotrexate—lymphatic system cancer	0.0005	0.000564	CcSEcCtD
Captopril—Vomiting—Methotrexate—lymphatic system cancer	0.000481	0.000542	CcSEcCtD
Captopril—Rash—Methotrexate—lymphatic system cancer	0.000477	0.000538	CcSEcCtD
Captopril—Dermatitis—Methotrexate—lymphatic system cancer	0.000476	0.000537	CcSEcCtD
Captopril—Headache—Methotrexate—lymphatic system cancer	0.000474	0.000534	CcSEcCtD
Captopril—Nausea—Methotrexate—lymphatic system cancer	0.000449	0.000507	CcSEcCtD
